Navigation Links
CRH provides Partnership Program update

VANCOUVER, Feb. 24 /PRNewswire-FirstCall/ - CRH Medical Corporation announced today that through its Partnership Program, the CRH O'Regan Hemorrhoid banding technology has been adopted by more than 90% of the gastroenterologist practice groups trained by the Company since June 2008. The Company believes this provides clear evidence of not only a strong medical need, but also confirmation of the consistency of its training methodology. The sharing of knowledge and experience from our CRH Centers for Colorectal Health to individual physicians through our Partnership Program has gone smoothly, with continued high levels of safety and successful treatment outcomes.

The Company has now trained over two hundred physicians representing over 40 practice groups in 30 markets across the United States. The diagnosis of hemorrhoids requiring treatment during colonoscopy is very common. The CRH technology provides physicians with an effective modality to treat hemorrhoidal disease. It is clear by the significant adoption rate amongst physicians that the treatment of hemorrhoids is a natural extension of their practice. With over 8,000 gastroenterologists in the U.S. alone, the Company expects to significantly increase its efforts under the Partnership Program.

Commenting on the success of the Partnership Program, Edward Wright, Chief Executive of CRH said, "I am delighted to report that our new physician partners are reporting the same outstanding clinical outcomes that we experienced in treating over 50,000 hemorrhoids in our own Centers in the U.S." Wright further stated, "The Company expects to train in excess of 75 physicians in approximately 20 practices groups during the first quarter of 2009."

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

For further information call Dean Linden, Corporate Communications, CRH Medical Corporation at 604.633.1440 or Additional information may also be found by visiting the Company's website at or the SEDAR website at

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.

SOURCE CRH Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
(Date:11/28/2015)... ... 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, ... savings of up to 20% off orders $80 or more to free gifts with purchases, ... hours. , As a competitive e-commerce website for skin care and cosmetic needs, customers will ...
(Date:11/27/2015)... ... , ... According to an article published November 13th on, ... D.C. revolved around the fact that proper dental care, both at-home and in the ... between periodontal disease (more commonly referred to as gum disease) and diabetes. According to ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set of ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... , 26 november 2015 AAIPharma ... de geplande investering aan van ten minste ... laboratoria en het mondiale hoofdkantoor in ... zal resulteren in extra kantoorruimte en extra ... de groeiende behoeften van de farmaceutische en ...
(Date:11/26/2015)... -- --> --> Juntendo ... optimal contrast weighting of MRI for patients with Multiple ... research agreement with SyntheticMR in order to use SyMRI in ... possible to generate multiple contrast images from a single scan ... thus making it possible to both fine tune images and ...
Breaking Medicine Technology: